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Abstract
In contrast to the experience in other European countries, the onset of the A(H1N1)2009 influenza virus epidemic was unexpectedly
slow in France during the first part of autumn 2009. Our objective was to test the hypothesis that intense circulation of rhinoviruses
might have reduced the probability of infection by A(H1N1)2009 virus at the beginning of autumn 2009. Systematic analysis for the
detection of A(H1N1)2009 (H1N1) and human rhinovirus (HRV) was performed by RT-PCR from week 36 to week 48 on respiratory
samples sent to the diagnostic laboratory by the paediatric hospital (n = 2121). Retrospective analysis of the obtained data, using 2 · 2
contingency tables with Fisher’s exact test, revealed evidence of an inverse relationship between HRV and H1N1 detection. Between
weeks 36 and 48 of 2009, both HRV and H1N1 were detected but in different time frames. HRV dispersed widely during early Septem-
ber, peaking at the end of the month, whereas the H1N1 epidemic began during mid-October and was still active at the end of this sur-
vey. During the co-circulation period of these two respiratory viruses (weeks 43–46), HRV detection appeared to reduce the likelihood
of H1N1 detection in the same sample (OR = 0.08–0.24 p <0.0001). These results support the hypothesis that HRV infections can
reduce the probability of A(H1N1) infection. This viral interference between respiratory viruses could have affected the spread of the
H1N1 viruses and delayed the influenza pandemic at the beginning of autumn in France.
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Introduction
Six months after its emergence in North America, the novel
swine-origin influenza virus A(H1N1)2009 had spread world-
wide, causing many countries to initiate their pandemic con-
trol plans [1]. It is believed that large-scale air transportation
of humans with H1N1 infections were responsible for the
early reports of outbreaks in Europe (Portugal, Great Britain,
Spain) [2]. A combination of atmospheric conditions [3] and
the introduced containment procedures may have been
responsible for sporadic circulation of the virus in Europe
from April to the end of August [4]. However, by September
the dry and cold weather, together with the resulting altered
social behaviour (increased indoor activity), usually leads
to the appearance of human rhinovirus (HRV), seasonal
influenza, and respiratory syncytial virus (RSV) infections.
Therefore, it was predicted by most experts that the H1N1
virus would quickly reach epidemic levels, spreading through-
out Europe, by early October, and that children would play
a major role in the dissemination of the virus as observed in
the southern hemisphere.
As anticipated the epidemic status of H1N1, based on
reports of Influenza Like Illness (ILI), was declared in France
during the first week of September (week 36) [5]. However,
these reports contrasted with the low incidence of H1N1
infection reported in the community by the Groupe Regional
d’Observation de la Grippe (GROG) – an influenza network
based on laboratory confirmation of samples provided by vol-
unteer practitioners [6]. From week 36 to week 43 this net-
work was reporting sporadic H1N1 activity but did not report
epidemic status of H1N1 until week 44 (mid-October). A
similar pattern was observed in Sweden [7]. It has been sug-
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gested by Linde et al. [7] that HRV could have been responsible
for the apparent increase of ILI reported in early September,
and might have delayed onset of the H1N1 pandemic.
The aim of our study was to test the hypothesis that
HRV reduced the probability of H1N1 infection in France
at the beginning of Autumn 2009. From the beginning of
September to the end of October, samples collected from
ILI cases visiting the emergency ward of the paediatric hos-
pital were tested by PCR-based methods for the two
viruses. Whether or not there was a correlation between
HRV and H1N1 incidence was analysed using a statistical
approach.
Materials and Methods
Clinical specimens and population
In total, 2121 paediatric samples were sent to the laboratory
for H1N1 detection between weeks 36 and 48 by the practi-
tioners at the Femme Me`re Enfant Hospital.
Among these, 1456 samples (68.6%) were also tested for
HRV positivity. The specimens consisted of nasopharyngeal
swabs (84.9%), nasopharyngeal aspirates (9.5%), nasal swabs
(4.6%), and tracheobronchial aspirates (1%).
Samples were collected in Virocult transport medium, and
immediately sent to the laboratory for analysis. The mean pop-
ulation age was 3.8 years (4.4 SD) with 55.3% being males.
Many of the patients had been admitted to the paediatric
emergency unit (73.2%) or the intensive care unit (4.6%).
Rhinoviruses and influenza RT-PCR assays
Nasopharyngeal samples were extracted by automatic stan-
dard procedures using NucliSens easyMAG instrument (Bio-
merieux, Marcy L’e´toile). The detection of HRV was
performed using an in-house real-time RT-PCR method.
Primers and probes were derived from sequences located in
the 5¢ non-coding region of the HRV genome [8].
The detection of H1N1 viruses was performed using two
RT-PCR assays. The first RT-PCR used universal primers
based on M gene detection for type A influenza virus [9].
The primers used for the M RT-PCR were previously
described for a classical RT-PCR and the probe was designed
on Primer Express software. Specificity of oligonucleotides
was assessed by a local alignment search (blastn; http://blas-
t.ncbi.nlm.nih.gov./Blast.cgi). The second RT-PCR assay was
designed for the specific detection of the H1N1 haemaggluti-
nin, and was kindly provided by V. Enouf and S. van der
Werf (NIC North of France, Institut Pasteur, Paris). The
primers and probe designed for the specific H1 RT-PCR are
available upon request (grippe@pasteur.fr).
The RT-PCRs were all performed on the ABI 7500
(Applied Biosystems, Foster City, CA, USA) platform, using
SuperScript III Platinum One-Step Quantitative RT-PCR Sys-
tem (Invitrogen, Carlsbad, CA, USA) and optimized with
0.8 lM primer, 0.2lM probe and 0.5lL enzyme mix (primers
and probe sequences are available on request). After reverse
transcription at 50C for 15 min and denaturation at 95C
for 2 min, a two-step amplification in 50 cycles was
performed at 95C for 15 s and 60C for 40 s. Negative
controls were included in each experiment.
Statistical analysis
Analysis for a correlation between HRV and H1N1 was per-
formed using 2 · 2 contingency tables with Fisher’s exact
test. Odds ratio (OR) and 95% confidence interval (CI) for
the likelihood of co-detection were calculated (Table 2). Dif-
ferences in age according to number of co-detections and
detection of HRV were compared using the Kruskal–Wallis
test. Significance level was set at p 0.05.
Results
Virus detection between weeks 36 and 48
At least one virus each was detected in 925 specimens
(43.6%). Relative frequencies of H1N1 and HRV were,
respectively, 28.9% (525/1815) and 24% (415/1731); 15
co-infections were observed (0.7%). However, during the
study period, HRV and H1N1 had distinctly different distri-
butions (Fig. 1). An epidemic due to HRV began at week 37
(relative frequency 20.6%). It peaked at week 40 (relative fre-
quency 36.8%) and then gradually diminished to a relative
frequency of 4.6% by week 45. In contrast, the epidemic due
to H1N1 began later, at week 43, with a relative frequency
of 18.8%, and it was still active at week 48, when the HRV
epidemic had subsided.
From week 43 to week 47 the HRV and H1N1 viruses
co-circulated in this French population, with, respectively,
17.7% and 42.9% relative frequency. Interestingly, over all the
study period there was a significant difference (p <0.0001) in
TABLE 1. Absolute numbers of cases of H1N1 and HRV
detected in various age groups
Age
<1 year
Age
1–5 years
Age
6–10 years
Age
>10 years
Cases of H1N1detected 73 208 166 78
Cases of HRV detected 160 197 39 19
Cases of co-infections
detected
3 6 5 1
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age amongst the patients positive for HRV (mean of 2.4 years,
SD 3.4) and H1N1 (mean of 5.6 years, SD 4.3) (Table 1).
Also, the HRV detected during the studied period were
from different sub-types (data not shown; I. Schuffenecker,
National Enteroviruses Centre, Lyon, France).
Virus co-detection
Overall, 15 samples were positive for both H1N1 and HRV.
This represented 4.6% and 25.9% H1N1 positive relative fre-
quency, considering the HRV-positive and -negative speci-
mens, respectively. The odds ratio was estimated to be 0.14
(0.08; 0.24 IC95) p <0.0001.
During the co-circulation period from weeks 43–47 and
among the different age groups a higher proportion of H1N1
detections was observed in the HRV negative samples. As
reflected by an odds ratio <1, HRV detection resulted in a
reduced likelihood of co-detecting H1N1 (Table 2).
Discussion
Our results suggest that the ILI activity reported in France
during early autumn 2009 was initially caused by HRV and
then from mid-October by H1N1. Moreover, in any single
respiratory sample analysed, detection of HRV resulted in
reduced likelihood of detection of the H1N1 virus. Thus, the
results showed a significant inverse relationship between
HRV and H1N1 virus irrespective of the time period and age
group analysed. Therefore, our data support a previous sug-
gestion that the presence of HRV reduces the risk of infec-
tion by the H1N1 virus and thus, indirectly, the spread of
the virus. The fact that several early studies had reported
the absence of co-epidemic respiratory viruses [6,10,11] may
explain why interference with influenza epidemicity has only
recently been observed.
In contrast to previous studies, our samples were derived
primarily from the paediatric emergency department and
thus are not representative of the situation in adult popula-
tions. Nevertheless, our analysis of a paediatric cohort of
patients infected with HRV and/or H1N1 supports and
extends the findings of Linde et al. [7] who postulated that
rhinovirus epidemics that occur after commencement of the
school year may interfere with the spread of influenza during
a period with a warm and humid climate that decreases
spread of influenza by aerosol. Our observations are also
consistent with the findings of Greer et al. [10] who identi-
fied similar negative associations between detection of HRV
and co-detection of different respiratory viruses, including
influenza A viruses.
Some known biological features of these viruses could
provide insights into the possible mechanisms involved in
these virus interactions. It is known that these viruses do
not bind the same receptors in the cells of the respiratory
tract, which correspond to human intercellular adhesion
molecule-1 (ICAM-1) for HRV and sialic acid alpha 2–6 for
human influenza viruses [12,13]. Interference could possibly
result from the non-specific innate immune response. Indeed,
it has been reported that the interferon response induces a
refractory state to virus infection of neighbouring cells.
Therefore, during HRV infection and shedding, a refractory
period may develop when superinfection of respiratory cells
by other respiratory viruses is inhibited [14].
The duration of this refractory period remains to be
determined. Based on our data it appears that it could
persist throughout the period when it remains possible to
detect the interfering virus, i.e. several weeks [15].
Additional epidemiological investigations with multiple serial
sampling will be required to extend our understanding of this
phenomenon.
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FIG. 1. Absolute numbers of H1N1 and rhinoviruses isolated in
samples provided by Hoˆpital Femme Me`re Enfant units, each week.
TABLE 2. Odds ratio (OR) and 95%
confidence interval (CI) for the like-
lihood of H1N1 detection in HRV
positive samples
Outcome of interest Factors p <0.05 Odds Ratio
Confidence
interval 95% p-value
H1N1 positive weeks 36–48 Rhinovirus positive 0.15 0.09–0.24 p <0.0001
H1N1 positive weeks 43–47 Rhinovirus positive 0.17 0.10–0.30 p <0.0001
H1N1 positive age <1 year Rhinovirus positive 0.16 0.05–0.5 p 0.0002
H1N1 positive age 1–5 years Rhinovirus positive 0.15 0.06–0.33 p <0.0001
H1N1 positive age 6–10 years Rhinovirus positive 0.14 0.05–0.39 p <0.0001
H1N1 positive age >10 years Rhinovirus positive 0.12 0.02–0.97 p 0.014
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These data are important firstly because they may reflect
the impact of such viral interference on prediction models of
influenza virus dispersal. Such prediction models are a key
feature for rational decision making in disease control. Sec-
ondly, it has been suggested that co-infection could trigger
multiple pandemic waves [16]. Thirdly, current preliminary
evidence [10] supports the notion that HRV may provide
a temporary window of protection against influenza virus
infection.
Further investigations are now in hand to elucidate other
aspects of such multiple virus interactions such as the impact
of H1N1 infection on children under 2 years of age when
there is a high risk of infection by RSV. Finally, one can ask
the question, does pandemic influenza virus limit the spread
of seasonal influenza viruses, as has been reported in the
southern hemisphere [17]?
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